|
| Exchange Disseminated Time 14/08/2019 14:10:45 | | With reference to news appeared in www.bloombergquint.com dated August 14, 2019 quoting "Setback For Dr. Reddy s As U.S. FDA Hands Out Complete Response Letter For NuvaRing", Dr Reddys Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. |
|
|